DD

Do You Have a Position in DuPont de Nemours? Here's the Essential Facts.

Shares of DuPont de Nemours have moved -0.6% today, and are now trading at a price of $70.0. In contrast, the S&P 500 index saw a -0.0% change. Today's trading volume is 986,136 compared to the stock's average volume of 3,465,262.

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. Based in Wilmington, United States the company has 23,000 full time employees and a market cap of $32,131,188,736. DuPont de Nemours currently offers its equity investors a dividend that yields 1.9% per year.

The company is now trading -23.73% away from its average analyst target price of $91.78 per share. The 18 analysts following the stock have set target prices ranging from $76.0 to $108.0, and on average give DuPont de Nemours a rating of buy.

The stock's 52 week high is $78.4 per share whereas its 52 week low is $49.52. Based on DuPont de Nemours's compound average gross margins growth rate of 0.6% over the last 4 years, its core business remains strong and the stock price may maintain this level of performance.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 13,017,000 8,402,000 35.45 -3.06
2021-12-31 12,566,000 7,971,000 36.57 8.48
2020-12-31 20,397,000 13,522,000 33.71 -2.74
2019-12-31 21,512,000 14,056,000 34.66 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS